Medicines Co. (MDCO) Posts Q1 Loss of $1.03/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. ON
6. CRWD
7. HNGE
8. INSP
9. MTCH
10. CVI

Go back to Medicines Co. (MDCO) Posts Q1 Loss of $1.03/Share

Chiesi to Acquire Medicines Co.'s (MDCO) Cleviprex, Kengreal, and Rights to Argatroban

May 9, 2016 7:08 AM EDT

The Medicines Company (NASDAQ: MDCO) announced that it has entered into a definitive agreement to sell Cleviprex (clevidipine), Kengreal (cangrelor) and the Companys rights to Argatroban for Injection to Chiesi USA, Inc. and its parent company, Chiesi Farmaceutici S.p.A., for up to $792 million, consisting of $260 million in cash payable at closing, up to $480 million in sales-based milestone payments, the assumption by Chiesi of up to $50... More